News
Supriya Lifescience standalone net profit declines 30.90% in the June 2026 quarter
14-Aug-2026 | 07:42
Sales rise 30.80% to Rs 189.75 crore
Net profit of Supriya Lifescience declined 30.90% to Rs 24.04 crore in the quarter ended June 2026 as against Rs 34.79 crore during the previous quarter ended June 2025. Sales rose 30.80% to Rs 189.75 crore in the quarter ended June 2026 as against Rs 145.07 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 189.75 | 145.07 | 31 |
| OPM % | 25.01 | 35.64 | - |
| PBDT | 49.73 | 53.87 | -8 |
| PBT | 40.79 | 47.42 | -14 |
| NP | 24.04 | 34.79 | -31 |
Powered by Capital Market - Live News